3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with oxidopamine in 1 studies
| Studies (3-(2,4-dimethoxybenzylidene)anabaseine) | Trials (3-(2,4-dimethoxybenzylidene)anabaseine) | Recent Studies (post-2010) (3-(2,4-dimethoxybenzylidene)anabaseine) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 166 | 8 | 81 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | 3-(2,4-dimethoxybenzylidene)anabaseine (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hisahara, S; Kawamata, J; Kem, W; Kitamura, Y; Matsumura, A; Matsushita, T; Shimohama, S; Suzuki, S; Takata, K | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and oxidopamine
| Article | Year |
|---|---|
3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Female; Neurodegenerative Diseases; Neuroprotective Agents; Nicotinic Agonists; Oxidopamine; Parkinson Disease; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2013 |